PZ Cormay S.A. Logo

PZ Cormay S.A.

Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.

CRM | WAR

Overview

Corporate Details

ISIN(s):
PLCMRAY00029
LEI:
2594006HZJ8OSNK56U87
Country:
Poland
Address:
Warszawa Puławska 303, 02-785 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PZ Cormay S.A. is a manufacturer and distributor of comprehensive solutions for the in-vitro diagnostics (IVD) market. With nearly 40 years of experience, the company specializes in producing high-quality diagnostic reagents and distributing advanced laboratory analyzers. Its product portfolio covers key areas of laboratory medicine, including clinical chemistry, hematology, immunology, and coagulology. The group integrates its reagent manufacturing expertise with the advanced hematology technology of its Swiss subsidiary, Orphee. Cormay provides reliable, high-performance, and cost-effective diagnostic systems to a global network of distributors, clinics, and laboratories for both human and veterinary medicine, committed to delivering trusted test results to aid in accurate medical diagnoses.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 06:39
Regulatory Filings
zal01_Raport_III_kwartal_2025_GK_CORMAY_PZ_CORMAY_S.A..pdf
Polish 1.8 MB
2025-10-27 12:09
Declaration of Voting Results & Voting Rights Announcements
zal01_RB_11_2025.pdf
Polish 129.5 KB
2025-10-27 12:09
Report Publication Announcement
Lista akcjonariuszy posiadających co najmniej 5% liczby głosów na NWZ PZ CORMAY…
Polish 152 bytes
2025-10-27 12:08
AGM Information
zal01_Tresc_uchwal_NWZ_PZ_CORMAY_S.A._27.10.2025.pdf
Polish 220.2 KB
2025-10-27 12:08
Report Publication Announcement
Treść uchwał NWZ PZ CORMAY S.A., które odbyło się w dniu 27.10.2025 r. - Conten…
Polish 152 bytes
2025-10-01 09:25
Pre-Annual General Meeting Information
zal01_Ogloszenie_projekty_uchwal_NWZ_PZ_CORMAY_S.A._27.10.2025.pdf
Polish 310.6 KB
2025-10-01 09:25
Report Publication Announcement
Ogłoszenie o zwołaniu NWZ PZ CORMAY S.A. na dzień 27.10.2025 r. (wraz z projekt…
Polish 152 bytes
2025-09-26 07:51
Audit Report / Information
zal02_4._Raport_z_przegladu_PZ_CORMAY_S.A._I_polrocze_2025.pdf
Polish 383.3 KB
2025-09-26 07:51
Audit Report / Information
zal03_3._Raport_z_przegladu_GK_CORMAY_I_polrocze_2025.pdf
Polish 364.5 KB
2025-09-26 07:51
Management Reports
zal04_2._Sprawozdanie_Zarzadu_GK_CORMAY_I_polrocze_2025.pdf
Polish 739.1 KB
2025-09-26 07:51
Interim / Quarterly Report
zal01_1._Sprawozdania_finansowe_GK_CORMAY_PZ_CORMAY_S.A_I_polrocze_2025.pdf
Polish 1.8 MB
2025-09-24 15:26
Related Party Transaction
Zgoda Rady Nadzorczej PZ CORMAY S.A. na zawarcie oraz zawarcie aneksów do umów …
Polish 2.0 KB
2025-05-22 12:27
AGM Information
Powołanie osób zarządzających PZ CORMAY S.A. - Content (PL)
Polish 2.9 KB
2025-05-22 12:27
AGM Information
Powołanie osób nadzorujących PZ CORMAY S.A. - Content (PL)
Polish 7.4 KB
2025-05-22 12:26
Declaration of Voting Results & Voting Rights Announcements
zal01_RB_5_2025.pdf
Polish 122.4 KB

Automate Your Workflow. Get a real-time feed of all PZ Cormay S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PZ Cormay S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PZ Cormay S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cartesian Therapeutics, Inc. Logo
Pioneering mRNA-engineered cell therapies to treat autoimmune diseases.
United States of America
RNAC
CASI Pharmaceuticals, Inc. Logo
Develops and commercializes drugs for oncology, transplant, and autoimmune disease.
United States of America
CASI
CASSAVA SCIENCES INC Logo
Clinical-stage biotech developing oral drug simufilam for CNS disorders like TSC-related epilepsy.
United States of America
SAVA
CATALYST PHARMACEUTICALS, INC. Logo
Advancing therapies for rare neuromuscular and neurological diseases like LEMS.
United States of America
CPRX
cbdMD, Inc. Logo
Produces & distributes lab-tested CBD wellness products for people and pets.
United States of America
YCBD
CDT Equity Inc. Logo
Clinical-stage biopharma using AI to enhance and advance therapies for unmet medical needs.
United States of America
CDT
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom
CEL
Celcuity Inc. Logo
Developing targeted PI3K/mTOR inhibitor therapies for breast and prostate solid tumors.
United States of America
CELC
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea
331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea
308430

Talk to a Data Expert

Have a question? We'll get back to you promptly.